NCT04463875View on ClinicalTrials.gov

Magnesium, Vitamin B2, Feverfew, Andrographis Paniculata and Coenzyme Q10 for Episodic Migraine Prophylaxis

CompletedOBSERVATIONAL
Enrollment

113

Participants

Timeline

Start Date

April 1, 2018

Primary Completion Date

April 30, 2020

Study Completion Date

May 31, 2020

Conditions
Migraine
Interventions
DIETARY_SUPPLEMENT

magnesium, vitamin B2, feverfew, andrographis paniculata and coenzyme Q10

Supplementation per os

Trial Locations (1)

49100

Corfu HC, Corfu

All Listed Sponsors
lead

Corfu Headache Clinic

OTHER

NCT04463875 - Magnesium, Vitamin B2, Feverfew, Andrographis Paniculata and Coenzyme Q10 for Episodic Migraine Prophylaxis | Biotech Hunter | Biotech Hunter